Market Update: S&P/ASX200 Ended in Red; APE Soared by 13.333%

  • Jul 29, 2020 AEST
  • Team Kalkine
Market Update: S&P/ASX200 Ended in Red; APE Soared by 13.333%

On 29th July 2020, the equity market of Australia ended in red, and S&P/ASX200 went down by 14.1 points to 6006.4. During the last five days, the index has lost 1.13%. S&P/ASX 200 Materials (Sector) settled at 14,270.0, reflecting a fall of 250.7 points. S&P/ASX 200 Information Technology (Sector) moved down by 1.56% to 1,629.2.

On ASX, the share price of AP Eagers Limited (ASX: APE) settled at $7.990 per share. The stock of PolyNovo Limited (ASX: PNV) stood at $2.270 per share with a rise of 3.182%.

Stock Performance (Source: ASX)

S&P/NZX50 settled the session at 11,599, reflecting a rise of 0.18%. The share price of New Talisman Gold Mines Limited (NZX: NTL) rose by 14.29% to NZ$$0.008 per share. The stock of Plexure Group Limited (NZX: PLX) inched up by 9.09% to NZ$1.320. However, the share price of Blackwell Global Holdings Limited (NZX: BGI) moved down by 15.00% to NZ$0.017 per share.

On the same day, the share price of Wellington Drive Technologies Limited (NZX: WDT) witnessed a fall of 5.71% on an intraday basis to NZ$0.066 per share. Also, the stock of T&G Global Limited (NZX: TGG) encountered a decline of 5.20% to NZ$2.550 per share.

Recently, we have written an article on Mount Burgess Mining NL (ASX:MTB), and the readers can view the content by clicking here.

AP Eagers Limited Finished 2019 Annual General Meeting on 29th July 2020.

AP Eagers Limited (ASX: APE) recently completed its 2019 Annual General Meeting, wherein all resolutions were passed on a poll. The Chairman of the company stated that the group recorded a statutory loss after tax amounting to $80.5 million for the year to December 31, 2019. The group managed to deliver underlying operating profit before tax of $100.4 million despite challenging market conditions.

PolyNovo Limited Ended in Green on Australian Securities Exchange.

PolyNovo Limited (ASX: PNV) recently advised the market that it has received funding of US$15 million from BARDA to support the Pivotal trial program of NovoSorb BTM. The company would make a modest co-funding and “in kind” contribution to the trial with the final budget to be announced after the US FDA approval.

With respect to the US, the company stated that June 2020 was the new record sales month.

The company has opened 7 new hospital accounts since the record sales month announced on 7th April.

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. All pictures are copyright to their respective owner(s). Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK